Trial Condition(s):
Hypertension, Pulmonary
Epidemiology and treatment patterns of paediatric PAH (Pulmonary arterial hypertension)
Bayer Identifier:
18515
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013
Inclusion Criteria
- All PAH patients who were in the MarketScan database and who were under age 18 at some time during the years 2010 through 2013
Exclusion Criteria
Not applicable
Trial Summary
Enrollment Goal
2691
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Investigative Site Boston, United States | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Study to Estimate the Incidence and Prevalence and treatment patterns of Pediatric Pulmonary Hypertension in the US
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Incidence rate of PAH (pulmonary arterial hypertension)Timeframe: Retrospective analysis of three year period
- Prevalence rate of PAHTimeframe: Retrospective analysis of three year period
Secondary Outcome
- Assigned drug treatment for PAH measured using the MarketScan databaseDescription of pulmonary hypertension-targeted drugs prescribed in the study population and changes during the study periodTimeframe: Retrospective analysis of three year period
- Diagnostic procedures performed among PAH patients measured using the MarketScan databaseTimeframe: Retrospective analysis of three year period
- Prevalence of comorbidities among PAH patientsTimeframe: Retrospective analysis of three year period
Additional Information
Copyright © Bayer
Powered by
